Healthtech company develops AI software to control river blindness

An Indian healthtech company has announced it will develop an artificial intelligence (AI) based computer aided-software for controlling spread of River Blindness.

Niramai will use its Termalytix technology to detect the presence of live adult worms of Onchocerciasis which causes river blindness and significant disability. The technology is currently being applied to early stage breast cancer detection. This non-invasive detection method is expected to help assess the efficacy of new drugs being developed to control the disease by killing the adult worms, potentially accelerating the elimination of river blindness. The project is being supported by the Bill & Melinda Gates Foundation.

Thermalytix is an automated diagnostic tool, which combines thermal imaging with artificial intelligence.

Dr Geetha Manjunath, CEO & CTO, Niramai, said: “We are very excited to collaborate with Gates Foundation to extend the application of our innovative technique to areas other than breast cancer. Successful completion of this research project will demonstrate a breakthrough result of Thermalytix being a new way of sensing many abnormalities in human body in a non-invasive, radiation-free and accurate way, even beyond cancer!”

'Healthtech company develops AI software to control river blindness' has no comments

Be the first to comment this post!

Would you like to share your thoughts?

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

© 2019 Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved.

Privacy policy

Terms and conditions